{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:06:27Z","timestamp":1778411187818,"version":"3.51.4"},"reference-count":54,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with sickle cell disease (SCD) are at a risk of thromboembolism (TE), and use of hormonal contraception can further increase that risk. This study aims to assess patterns of hormonal contraceptive use and compare risk of contraception-related TE between combined hormonal contraceptives (CHCs) and progestin-only contraceptives (POCs). Patients with SCD aged between 12 and 44 years with a new prescription of a hormonal contraceptive in the Centers for Medicare and Medicaid Services Medicaid Analytic eXtract database (2006-2018) were followed up to 1 year. We identified 7173 new users: 44.6% initiated CHC and 55.4% initiated POC. Combined oral contraceptive pills (OCPs; 36.5%) and progestin-only depot medroxyprogesterone acetate (33.9%) were the most frequently prescribed agents. A total of 1.8% of contraception users had a new diagnosis of TE within 1 year of the first identified contraception prescription. There were no significant differences in TE event rates between CHC and POC users (17.2 and 24.7 events per 1000 person-years, respectively). In patients prescribed OCP, there were no differences in TE event rates based on estrogen dose or progestin generation. Transdermal patch had a 2.4-fold increased risk of TE as compared with that of OCP. Although limited by the retrospective study design and use of administrative claims data, this study found no significant differences in TE rates between new users of CHC and POC in patients with SCD. Careful evaluation of underlying TE risk factors should be considered for each patient with SCD before initiation of hormonal contraception.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010204","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:34:06Z","timestamp":1692207246000},"page":"6140-6150","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3348-2045","authenticated-orcid":false,"given":"Natasha S.","family":"Bala","sequence":"first","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/BMT, Nationwide Children's Hospital and The Ohio State University, College of Medicine, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-2102","authenticated-orcid":false,"given":"Joseph R.","family":"Stanek","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/BMT, Nationwide Children's Hospital and The Ohio State University, College of Medicine, Columbus, OH"},{"name":"2Biostatistics Resource at Nationwide Children's Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-0156","authenticated-orcid":false,"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics and Epidemiology, Hudson College of Public Health, The University of Oklahoma, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-6521","authenticated-orcid":false,"given":"Robert M.","family":"Cronin","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, The Ohio State University, College of Medicine, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-8139","authenticated-orcid":false,"given":"Susan E.","family":"Creary","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/BMT, Nationwide Children's Hospital and The Ohio State University, College of Medicine, Columbus, OH"},{"name":"5Center for Child Health Equity and Outcomes Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[{"name":"6Department of Obstetrics and Gynecology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-6784","authenticated-orcid":false,"given":"Wendy","family":"Xu","sequence":"additional","affiliation":[{"name":"7Division of Health Services Management and Policy, The Ohio State University, College of Public Health, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-9746","authenticated-orcid":false,"given":"Sarah H.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/BMT, Nationwide Children's Hospital and The Ohio State University, College of Medicine, Columbus, OH"},{"name":"5Center for Child Health Equity and Outcomes Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"issue":"suppl 4","key":"2023102313311270700_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"6","key":"2023102313311270700_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjh.17658","article-title":"Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease","volume":"194","author":"Pecker","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"2023102313311270700_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2023102313311270700_bib4","doi-asserted-by":"crossref","first-page":"e2254552","DOI":"10.1001\/jamanetworkopen.2022.54552","article-title":"Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012-2018","volume":"6","author":"Early","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2023102313311270700_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AOG.0000000000004986","article-title":"Association of sickle cell disease with severe maternal morbidity","volume":"141","author":"Ha","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"17","key":"2023102313311270700_bib6","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1080\/14767058.2019.1671333","article-title":"Inpatient mortality and postpartum readmission rates in sickle cell disease pregnancies: a multistate analysis, 2007-2014","volume":"34","author":"Bae","year":"2021","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"21","key":"2023102313311270700_bib7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"issue":"4 suppl","key":"2023102313311270700_bib8","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1016\/j.amepre.2009.12.020","article-title":"Sickle cell disease and pregnancy outcomes: women of African descent","volume":"38","author":"Barfield","year":"2010","journal-title":"Am J Prev Med"},{"issue":"2","key":"2023102313311270700_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10995-012-1216-3","article-title":"Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population","volume":"17","author":"Boulet","year":"2013","journal-title":"Matern Child Health J"},{"issue":"1","key":"2023102313311270700_bib10","doi-asserted-by":"crossref","first-page":"203S","DOI":"10.1097\/01.AOG.0000559148.74589.08","article-title":"Unintended pregnancy among people with sickle cell disease or sickle cell trait [abstract]","volume":"133","author":"Piper","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2023102313311270700_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jfprhc-2013-100763","article-title":"Trends in family planning and counselling for women with sickle cell disease in the UK over two decades","volume":"41","author":"Eissa","year":"2015","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"issue":"5","key":"2023102313311270700_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2009.05.121","article-title":"Contraceptive usage among Jamaican women with sickle cell disease","volume":"80","author":"Knight-Madden","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"2023102313311270700_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/01443615.2016.1225023","article-title":"Contraceptive practices in women with sickle-cell disease","volume":"37","author":"Carvalho","year":"2017","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"5","key":"2023102313311270700_bib14","first-page":"552","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker","year":"2021","journal-title":"J\u00a0Natl Med Assoc"},{"key":"2023102313311270700_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.contraception.2021.08.009","article-title":"Contraceptive use and preferences among females with sickle cell disease","volume":"105","author":"Roe","year":"2022","journal-title":"Contraception"},{"issue":"6","key":"2023102313311270700_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jadohealth.2021.06.008","article-title":"Provider attitudes, preferences, and practices regarding sexual and reproductive health for adolescents and young adults with sickle cell disease","volume":"69","author":"Leroy-Melamed","year":"2021","journal-title":"J\u00a0Adolesc Health"},{"issue":"1","key":"2023102313311270700_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2003-38333","article-title":"Changes of hemostatic variables during oral contraceptive use","volume":"3","author":"Tans","year":"2003","journal-title":"Semin Vasc Med"},{"key":"2023102313311270700_bib18","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"2023102313311270700_bib19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/asheducation-2016.1.640","article-title":"Sickle cell disease: an inherited thrombophilia","volume":"2016","author":"Wun","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2023102313311270700_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.contraception.2011.10.008","article-title":"Contraception for individuals with sickle cell disease: a systematic review of the literature","volume":"85","author":"Haddad","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"2023102313311270700_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6504a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"2023102313311270700_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members [published correction appears in JAMA. 2014;312(18):1932] [published correction appears in JAMA. 2015;313(7):729]","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"2023102313311270700_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"2023102313311270700_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.contraception.2010.06.017","article-title":"Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims","volume":"83","author":"O'Brien","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"2023102313311270700_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14423\/SMJ.0000000000000949","article-title":"Contraceptive methods and the impact of menstruation on daily functioning in women with sickle cell disease","volume":"112","author":"Day","year":"2019","journal-title":"South Med J"},{"issue":"3","key":"2023102313311270700_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0033354919839072","article-title":"Improving an administrative case definition for longitudinal surveillance of sickle cell disease","volume":"134","author":"Snyder","year":"2019","journal-title":"Public Health Rep"},{"key":"2023102313311270700_bib27","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"2023102313311270700_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"key":"2023102313311270700_bib29","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"2023102313311270700_bib30","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"issue":"20","key":"2023102313311270700_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2023102313311270700_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"2023102313311270700_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2023102313311270700_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"18","key":"2023102313311270700_bib35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"issue":"2","key":"2023102313311270700_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"issue":"2 pt 1","key":"2023102313311270700_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users [published correction appears in Obstet Gynecol. 2008;111(6):1449]","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2023102313311270700_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"2023102313311270700_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"O'Brien","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"2023102313311270700_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"issue":"11","key":"2023102313311270700_bib41","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2023102313311270700_bib42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes [published correction appears in Obstet Gynecol. 2015;125(2):495]","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2023102313311270700_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","article-title":"Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density","volume":"112","author":"Berenson","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2023102313311270700_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","article-title":"Injectable hormone contraception and bone density: results from a prospective study [published correction appears in Epidemiology. 2002;13(6):749.]","volume":"13","author":"Scholes","year":"2002","journal-title":"Epidemiology"},{"issue":"4","key":"2023102313311270700_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajh.20541","article-title":"High prevalence and correlates of low bone mineral density in young adults with sickle cell disease","volume":"81","author":"Miller","year":"2006","journal-title":"Am J Hematol"},{"issue":"4","key":"2023102313311270700_bib46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.2006.06487.x","article-title":"Bone mass density in adults with sickle cell disease","volume":"136","author":"Sarrai","year":"2007","journal-title":"Br J Haematol"},{"issue":"388","key":"2023102313311270700_bib47","first-page":"1","article-title":"Current contraceptive status among women aged 15-49: United States, 2017-2019","author":"Daniels","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"1","key":"2023102313311270700_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2017.10.003","article-title":"Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014","volume":"97","author":"Kavanaugh","year":"2018","journal-title":"Contraception"},{"issue":"4","key":"2023102313311270700_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.29245\/2572-9411\/2017\/4.1124","article-title":"The accuracy of hospital ICD-9-CM codes for determining sickle cell disease genotype","volume":"2","author":"Snyder","year":"2017","journal-title":"J\u00a0Rare Dis Res Treat"},{"issue":"5","key":"2023102313311270700_bib50","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pbc.25432","article-title":"The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease","volume":"62","author":"Eisenbrown","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2023102313311270700_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1472-6963-14-70","article-title":"Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies","volume":"14","author":"Martin","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"2023102313311270700_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jval.2017.09.002","article-title":"Sensitivity of claims-based algorithms to ascertain smoking status more than doubled with meaningful use","volume":"21","author":"Huo","year":"2018","journal-title":"Value Health"},{"key":"2023102313311270700_bib53","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Fingar","year":"2019"},{"issue":"13","key":"2023102313311270700_bib54","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2024013554","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/20\/6140\/2085133\/blooda_adv-2023-010204-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/20\/6140\/2085133\/blooda_adv-2023-010204-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:32:16Z","timestamp":1698067936000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/20\/6140\/497457\/Comparison-of-thromboembolism-outcomes-in-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":54,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,10,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010204","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2024013554","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}